Google
EVAX — EVAXION BIOTECH AS (Healthcare >> Biotechnology)
EVAX FAQ
What is EVAX's P/E ratio?
EVAXION BIOTECH AS (EVAX) currently trades at a P/E ratio of 6.52.
What is EVAX's ROE?
EVAXION BIOTECH AS reports a Return on Equity (ROE) of 7.30%.
What is EVAX's dividend yield?
EVAXION BIOTECH AS offers a dividend yield of 0.00%.
What is EVAX's Deepscope Quality Score?
Deepscope rates EVAX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy EVAX?
Deepscope's AI Timing Score for EVAX is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does EVAX belong to?
EVAXION BIOTECH AS is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.64
Price
0.03
(0.83%)
Day Change
|
|
|---|
EVAX, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 78 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.64 |
| PBV / Sector |
2.28 / 4.91
|
| Earning Per Share | -1.18 |
| PE / Sector |
6.52 / 18.34
GREAT
|
| PEG or PE/Growth / Sector |
-0.11 / 0.61
|
| Average 1M Daily Value |
0.12 M
GREAT
|
| Average 1W Daily Value |
0.11 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
47% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-13 11:13:05 |
| Symbol | EVAX |
| Name | EVAXION BIOTECH AS |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 8.34 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 30.11 / 9,034.83 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Dr. Neergaards Vej, Horsholm, Denmark, 2970
Phone: 45 53 53 18 50
Website: https://evaxion.ai
Sector: Healthcare >> Biotechnology
Description: Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin and soft tissue infections with S. aureus bacteria; EVX-B2 to target multi-component prophylactic vaccine against gonorrhea bacteria; EVX-B3 to target bacterial pathogen associated with repeated infections; and EVX-V1, a multi-component prophylactic vaccine candidate for cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
